Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > He is trying to get out, with minimum damage, sell me your
View:
Post by Dude51 on Mar 05, 2021 1:32am

He is trying to get out, with minimum damage, sell me your

shares is all he is thinking. So for all that he is saying I have seen no proof of anything. Give us link to something bad. Just one valid link that proves the Scotty’s theory there just a shell company. Tell us about sleaze ball Andrew group, give me a break. You are entertaining, so thanks for that. The Salzman Group’s last contract with Barda was around 20 million of a total 69 million that was available. News flash, Salzman likes Claritas and visa versa that's good. Terrible Trump is gone, Biden believes in Science. He is rolling back everything else Trump has done, pertant neer. Barda has a new boss and my guess Andrew and the Ruffffians are going to get some contracts and my guess R-107 is going to get some fast track love from the FDA. So Pucker Up loser. You should take our advice and accumulate. What’s the goal? FDA anything with us is the goal, pertant neer, once Australia and human tests are done.
And this is another potential revenue stream we still got the Beetlebug and all their studies and experience with CBD and pain cures. I know it sure helped my 94 year old mother who suffered from arthritis. Within 20 minutes of first time, CBD eye dropper couple drops under tongue, it was gone for most if not all day.
So Minimum Schooling, where is that link to your fake news? Don't forget to watch our canary in the gold mine, SaNOtize, they have completed phase 2 trials....GLTA
Comment by Scotty on Mar 05, 2021 1:59am
Smart people got out during the greed run. Once KLY announces the level of dilution they need to cover all the gibs, not to mention the upcoming rs, you'll never see +.1 again. Time is running out guys, take what you can get.
Comment by PowerofNow on Mar 05, 2021 2:40am
Comment by Scotty on Mar 05, 2021 3:19am
Just warning new investors, huge dilution is coming. You're terrible at investing if you disagree.
Comment by noeIstrlfe on Mar 05, 2021 3:24am
Your fake fear tactics are almost as bad as the ksam sit
Comment by Dude51 on Mar 05, 2021 5:54am
Scotty - (3/5/2021 3:19:30 AM) RE:RE:RE:He is trying to get out, with minimum damage, sell me your Just warning new investors, huge dilution is coming. You're terrible at investing if you disagree. Ignore Scotty just more noise from a basher who sold his shares long ago at a loss and now thinks everyone else should lose their investment too, pathetic loser.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities